ARCHIVES

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

This article is from The Cancer Letter archive.

Vol. 22 No. 41 | October 24, 1996

Download PDF Visit The Full Archive

Related Articles

Advocacy: Groups Urge studies Of Environmental Pollutants As Cause Of Cancer

November 5, 1999

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

Lombardi Recruits Adams-Campbell.

October 3, 2008